Dx entrepreneurs buy Ivax stake from Teva
This article was originally published in Clinica
Executive Summary
Two healthcare entrepreneurs have bought Teva Pharmaceutical’s majority share in Ivax Diagnostics in a deal which they believe will help create “one of the leaders in the diagnostics market”.